Related Experiment Video
Updated: May 28, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Typhlitis in acute childhood leukemia
Esma Altınel1, Nese Yarali, Pamir Isık
1Department of Pediatric Hematology, Dr. Sami Ulus Children's Hospital, Ankara, Turkey.
Insights
Typhlitis occurred in 4.5% of children with acute leukemia, with a 20% mortality rate. Early medical intervention is crucial for improving outcomes in these pediatric oncology patients.
Area of Science:
- Pediatric Oncology
- Hematology
- Gastroenterology
Background:
- Typhlitis, also known as neutropenic enterocolitis, is a serious complication in pediatric patients undergoing chemotherapy for acute leukemia.
- Understanding the incidence, clinical presentation, and outcomes of typhlitis is vital for effective management.
Purpose of the Study:
- To review the experience with typhlitis in children treated for acute leukemia.
- To analyze the demographics, symptoms, and outcomes of typhlitis in this patient population.
Main Methods:
- Retrospective review of medical records of children with acute leukemia and typhlitis from 2006 to 2009.
- Data collected included demographics, symptoms, microbiological findings, and imaging results.
Main Results:
- Ten episodes of typhlitis (4.5%) occurred in 75 children with acute leukemia during 221 periods of severe neutropenia.
- Cumulative risk was 7.4% for acute lymphoblastic leukemia (ALL) and 28.5% for acute myeloid leukemia (AML).
- Common symptoms included abdominal pain, tenderness, and fever; mortality rate was 20%.
Conclusions:
- Typhlitis is a significant concern in pediatric acute leukemia patients, with a notable mortality rate.
- Prompt diagnosis and aggressive medical management are essential to reduce morbidity and mortality associated with typhlitis.
Objective:
To review our experience with typhlitis among children treated for acute leukemia.
Material And Methods:
The medical records of children with acute leukemia and typhlitis between 2006 and 2009 were reviewed for demographics and symptoms, and for microbiological and imaging findings.
Results:
In the 75 children with acute leukemia--54 with acute lymphoblastic leukemia (ALL) and 21 with acute myeloid leukemia (AML)--there were 10 episodes of typhlitis (4.5%) that developed during 221 periods of severe neutropenia. The cumulative risk of typhlitis was 7.4% in patients with ALL and 28.5% in patients with AML. Frequent symptoms were: abdominal pain and tenderness (100% each); fever and nausea (90% each); emesis (80%); diarrhea (50%), and hypotension, peritonitis and abdominal distension (10% each). The median duration of symptoms was 6 days (range: 2-11 days), and that of neutropenia 14 days (range: 3-25 days). All patients were treated medically and none surgically. Two patients died because of typhlitis and sepsis.
Conclusions:
In our study, the rate of typhlitis among leukemic children was 4.5%; however, the mortality rate was 20%. Thus, rapid identification and timely, aggressive medical intervention are necessary to reduce the morbidity and mortality from typhlitis.
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Streptococcal Pharyngitis
Tonsillitis II: Management
Acute Pyelonephritis I: Introduction

